Jane Street’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$68.4K Sell
40,494
-563,016
-93% -$1,000K ﹤0.01% 10838
2025
Q4
$857K Buy
603,510
+393,530
+187% +$573K ﹤0.01% 6457
2025
Q3
$344K Buy
209,980
+146,667
+232% +$163K ﹤0.01% 8642
2025
Q2
$46.3K Buy
+63,313
New +$54.7K ﹤0.01% 9199
2025
Q1
Sell
-22,246
Closed -$30.7K 9543
2024
Q4
$30.7K Sell
22,246
-45,360
-67% -$50.9K ﹤0.01% 9077
2024
Q3
$70.3K Sell
67,606
-140,867
-68% -$193K ﹤0.01% 9099
2024
Q2
$361K Sell
208,473
-153,089
-42% -$308K ﹤0.01% 7507
2024
Q1
$864K Sell
361,562
-192,334
-35% -$473K ﹤0.01% 5677
2023
Q4
$1.84M Buy
553,896
+315,258
+132% +$844K ﹤0.01% 4471
2023
Q3
$893K Sell
238,638
-248,995
-51% -$1.15M ﹤0.01% 5351
2023
Q2
$2.08M Buy
487,633
+380,692
+356% +$2.25M ﹤0.01% 4111
2023
Q1
$731K Buy
106,941
+93,730
+709% +$727K ﹤0.01% 5629
2022
Q4
$105K Sell
13,211
-10,596
-45% -$81.5K ﹤0.01% 8067
2022
Q3
$229K Sell
23,807
-64,002
-73% -$648K ﹤0.01% 7969
2022
Q2
$635K Buy
87,809
+35,421
+68% +$308K ﹤0.01% 6312
2022
Q1
$677K Buy
52,388
+35,782
+215% +$455K ﹤0.01% 6914
2021
Q4
$265K Sell
16,606
-19,784
-54% -$346K ﹤0.01% 8397
2021
Q3
$585K Sell
36,390
-9,775
-21% -$143K ﹤0.01% 6985
2021
Q2
$639K Buy
46,165
+21,745
+89% +$308K ﹤0.01% 6778
2021
Q1
$356K Sell
24,420
-25,260
-51% -$429K ﹤0.01% 7420
2020
Q4
$863K Buy
49,680
+3,342
+7% +$59.5K ﹤0.01% 4904
2020
Q3
$850K Buy
+46,338
New +$862K ﹤0.01% 4363
2020
Q1
Sell
-12,671
Closed -$228K 5349
2019
Q4
$228K Buy
12,671
+1,721
+16% +$31.7K ﹤0.01% 4584
2019
Q3
$222K Sell
10,950
-8,239
-43% -$165K ﹤0.01% 4534
2019
Q2
$424K Buy
+19,189
New +$333K ﹤0.01% 3789
2017
Q3
Sell
-19,279
Closed -$277K 4486
2017
Q2
$277K Buy
+19,279
New +$371K ﹤0.01% 3685

Other funds holding CHRS